FI20095550A0 - Vaginal delivery system - Google Patents

Vaginal delivery system

Info

Publication number
FI20095550A0
FI20095550A0 FI20095550A FI20095550A FI20095550A0 FI 20095550 A0 FI20095550 A0 FI 20095550A0 FI 20095550 A FI20095550 A FI 20095550A FI 20095550 A FI20095550 A FI 20095550A FI 20095550 A0 FI20095550 A0 FI 20095550A0
Authority
FI
Finland
Prior art keywords
delivery system
vaginal delivery
vaginal
delivery
Prior art date
Application number
FI20095550A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Christine Talling
Philip Owens
Gavin Wasserfall-Smith
Original Assignee
Bayer Schering Pharma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Oy filed Critical Bayer Schering Pharma Oy
Priority to FI20095550A priority Critical patent/FI20095550A0/en
Publication of FI20095550A0 publication Critical patent/FI20095550A0/en
Priority to PCT/FI2010/050396 priority patent/WO2010133761A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20095550A 2009-05-19 2009-05-19 Vaginal delivery system FI20095550A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20095550A FI20095550A0 (en) 2009-05-19 2009-05-19 Vaginal delivery system
PCT/FI2010/050396 WO2010133761A1 (en) 2009-05-19 2010-05-17 Intravaginal delivery system comprising one or more therapeutically active substances capable of preventing and/or treating vaginal infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20095550A FI20095550A0 (en) 2009-05-19 2009-05-19 Vaginal delivery system

Publications (1)

Publication Number Publication Date
FI20095550A0 true FI20095550A0 (en) 2009-05-19

Family

ID=40680732

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20095550A FI20095550A0 (en) 2009-05-19 2009-05-19 Vaginal delivery system

Country Status (2)

Country Link
FI (1) FI20095550A0 (en)
WO (1) WO2010133761A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CZ2010933A3 (en) * 2010-12-15 2011-08-31 Valosun A.S. Probiotic strains of Lactobacillus fermentum 16A/1 and Lactobacillus crispatus 13A and their use for vaginal application
IT1403661B1 (en) 2011-01-28 2013-10-31 Probiotical Spa EFFERVESCENT COMPOSITION IN THE SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR THE TREATMENT OF VAGINAL INFECTIONS.
ITMI20110792A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF BACTERIA BELONGING TO THE BIFIDOBACTERIUM TYPE FOR USE IN THE TREATMENT OF HYPERCOLESTEROLEMIA.
ITMI20110793A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
ITMI20110791A1 (en) 2011-05-09 2012-11-10 Probiotical Spa BACTERIA OF BACTERIA ABLE TO METABOLIZE THE OXALATES.
US9168303B2 (en) * 2011-07-15 2015-10-27 Universiteit Gent Intravaginal delivery system
ITRM20110477A1 (en) 2011-09-09 2013-03-10 Giovanni Mogna COMPOSITION INCLUDING N-ACETYLCISTEIN AND / OR LYSOZYME MICROINCAPSULATE GASTROPROTECT IN ASSOCIATION WITH PROBIOTIC BACTERES ABLE TO RESTORE THE BARRIER EFFECT OF THE STOMACH THAT IS LOST DURING THE PHARMACOLOGICAL TREATMENT OF
ITMI20111718A1 (en) 2011-09-23 2013-03-24 Probiotical Spa A WATERPROOF MOISTURE AND OXYGEN MATERIAL FOR PACKAGING DIETARY, COSMETIC AND MEDICINAL PRODUCTS.
ITMI20130794A1 (en) * 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF BACTERIAL VAGINOSIS.
ITMI20130793A1 (en) 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES.
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
EP3233098B1 (en) 2014-12-15 2024-05-29 The Johns Hopkins University Cvs transplantation for treatment of bacterial vaginosis
KR20240126072A (en) 2015-01-27 2024-08-20 더 존스 홉킨스 유니버시티 Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
ITUA20162013A1 (en) * 2016-03-24 2017-09-24 Probiotical Spa Composition based on lactic bacteria for the simultaneous treatment of vaginal infections of fungal and bacterial origin.
WO2017163216A1 (en) * 2016-03-24 2017-09-28 Probiotical S.P.A. Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections
IT201700014282A1 (en) * 2017-02-09 2018-08-09 Polymed S R L Device for intravaginal administration of substances.
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, DEVICE AND COMPUTER-READABLE MEDIA FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE RECORDING/FOCUS ZONES
MX2020012459A (en) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc IMPLANTABLE DEVICE FOR SUSTAINED RELEASE OF A MACROMOLECULAR DRUG COMPOUND.
KR20260007295A (en) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 Implantable device for sustained release of a macromolecular drug compound
GB2595187B (en) * 2019-01-31 2022-12-14 Kimberly Clark Co Methods and products for dynamic control of environments by selective metabolic function of microbes
US20220273686A1 (en) * 2019-08-06 2022-09-01 Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. Pharmaceutical composition for producing safe amount of nitric oxide and use thereof
WO2022115599A1 (en) 2020-11-25 2022-06-02 Oak Crest Institute Of Science Vaginal encapsulation devices
BR112023022439A2 (en) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc IMPLANTABLE DEVICE FOR SUSTAINED RELEASE OF A MACROMOLECULAR DRUG COMPOUND
CN114767685B (en) * 2022-04-25 2023-10-20 北京大学第三医院（北京大学第三临床医学院） Use of tetrahydrofolate for inhibiting bacteria or preventing or treating eye diseases

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95768C (en) * 1993-06-17 1996-03-25 Leiras Oy Intravaginal dosing system
US20050276836A1 (en) * 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
WO2003080813A2 (en) * 2002-03-21 2003-10-02 Bifodan A/S Lactobacillus strains
US20040022775A1 (en) * 2002-04-15 2004-02-05 Gregor Reid Methods of treating viral infections in mammals
US20030229335A1 (en) * 2002-04-30 2003-12-11 Payne Richard Grady Apparatus and method for delivery of constrained beneficial bacteria to the vaginal tract
EP1500394A1 (en) * 2003-07-22 2005-01-26 Polichem S.A. Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences
SE528382C2 (en) * 2004-10-05 2006-10-31 Probi Ab Probiotic lactobacillus strains for improved vaginal health
WO2007073264A1 (en) * 2005-12-22 2007-06-28 Sca Hygiene Products Ab Absorbent article
ITMI20061912A1 (en) * 2006-10-04 2008-04-05 S I I T Srl PHARMACEUTICAL COMPOSITIONS TOPIC VAGINAL
AU2006350771B2 (en) * 2006-11-17 2012-12-06 Sca Hygiene Products Ab Lactobacillus fermentum Ess-1, DSM17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
US20080254098A1 (en) * 2007-04-11 2008-10-16 Ehrlich Shelley R Neural tube birth defect reduction with folic acid delivery in catamenial hygiene products
US20090098188A1 (en) * 2007-10-11 2009-04-16 Staab Robert J Method for delivery of medication using a dissolvable device
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
WO2009155118A1 (en) * 2008-05-30 2009-12-23 Reprotect, Inc. Compositions and methods for inactivation of pathogens at genital tract surfaces
FI121000B (en) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginal delivery system and method for its preparation

Also Published As

Publication number Publication date
WO2010133761A1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
FI20095550A0 (en) Vaginal delivery system
DK2398500T3 (en) GLUTATHION-BASED PHARMACEUTICAL DELIVERY SYSTEM
EP2431009A4 (en) STENT DELIVERY SYSTEM
DK2440157T3 (en) LENS DELIVERY SYSTEM
EP2509515A4 (en) setting system
BRPI1014975A2 (en) implant delivery system
BRPI1010279A2 (en) drug delivery device
EP2523606C0 (en) TRANSCORPOREAL DELIVERY SYSTEM
DK2414011T3 (en) DRUG DELIVERY DEVICES
DK2493532T3 (en) Drug delivery device
DK2283904T3 (en) component System
EP2379922A4 (en) FLAP SYSTEM
BRPI1012730A2 (en) drug delivery device
HUE045856T2 (en) Intrauterine system
GB0903810D0 (en) Delivery system
FI20090081A0 (en) Elevator system
FI20085277A0 (en) Intrauterine system
DE102009035941B8 (en) diagnostic system
BRPI1010237A2 (en) drug delivery device
FI20105379L (en) Connector unit
HUE042614T2 (en) Felnyílómozgató system
BR112012000799A2 (en) drug delivery device
DK2437736T3 (en) drug delivery
FIU20090395U0 (en) Electronic document delivery system
DK2301611T3 (en) Drug delivery device

Legal Events

Date Code Title Description
FD Application lapsed